overlay image

Oral solid dose development capabilities at a glance

Oral Solids

  • Early-stage formulation development
  • Process validation and optimization
  • Full development of analytical methods
  • Scale-up from lab to pilot to commercial
  • Specification development
  • Regulatory support - pre- and post-launch
  • Clinical manufacturing Ph I - III
  • Full range of OEB 1-5
  • Tablets, Capsules, Granules
  • Controlled substances (III-IV)
Let’s collaborate

Expert Content

Find out how Pfizer CentreOne is ready to help meet your complex OSD needs, seamlessly and simply

Download Application Note

Explore the current market dynamics and the latest drug development trends driving these strategic outsourcing decisions

Download the White Paper

Making the complex simple: A roadmap for your OSD journey

Watch the Webinar

Opening the doors to opportunity

Clinical Phases

  • Development & manufacturing
  • Technical transfer
  • Formulation optimization
  • Scale-up/validation


  • CMC preparation
  • Final package
  • Pre-approval inspection


  • Drug to market
  • Production efficiency studies

Lifecycle Management

  • Cold-chain management
  • Supply/distribution
  • Drug delivery expansion

Explore our global oral solid dose development capabilities


Ascoli, Italy

  • OEB 1-5 facility with capacity to support you from pilot to commercial scale
  • 45+ years of proven expertise in complex and competitive oral solid dosages
  • Strong expertise in the containment and segregation of drug product materials
  • Five segregated areas for hormonal, cytotoxic and oncology drug product

Discover Ascoli


Freiburg, Germany

  • OEB 1-5 facility with capacity to support you from pilot to commercial scale
  • Capabilities in portable continuous miniature and modular manufacturing
  • Expertise in highly and non-highly potent products
  • A leading site for environmental protection and sustainability

Discover Freiburg

Freiburg Site

Newbridge Site


Newbridge, Ireland

  • OEB 1-5 facility with capacity to support you from pilot to commercial scale
  • 165B+ doses supplied to 150+ markets worldwide
  • Home to a 13,500-pallet automated warehouse (ASRS) and a wastewater treatment plant
  • Segregated area for hormonal drugs

Discover Newbridge


Nagoya, Japan

  • 55+ years of experience serving the Japanese market
  • Dedicated facility for high-contained products
  • Drug product manufacturing, primary and secondary packaging
  • Capabilities in the development of unique formulations such as Orally Disintegrating Tablets (ODT)

Discover Nagoya

Nagoya Site